September 2016
Volume 57, Issue 12
Open Access
ARVO Annual Meeting Abstract  |   September 2016
Effects of rho-associated protein kinase inhibitor Y-27632 on scarring formation after glaucoma filtration surgery
Author Affiliations & Notes
  • Hideaki Okumichi
    Department of Ophthalmology and Visual Science, Institute of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
  • Wakana Iwata
    Department of Ophthalmology and Visual Science, Institute of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
  • Satoshi Okimoto
    Department of Ophthalmology and Visual Science, Institute of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
  • Ji-Ae Ko
    Department of Ophthalmology and Visual Science, Institute of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
  • Yoshiaki Kiuchi
    Department of Ophthalmology and Visual Science, Institute of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan
  • Footnotes
    Commercial Relationships   Hideaki Okumichi, None; Wakana Iwata, None; Satoshi Okimoto, None; Ji-Ae Ko, None; Yoshiaki Kiuchi, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science September 2016, Vol.57, 2928. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Hideaki Okumichi, Wakana Iwata, Satoshi Okimoto, Ji-Ae Ko, Yoshiaki Kiuchi; Effects of rho-associated protein kinase inhibitor Y-27632 on scarring formation after glaucoma filtration surgery. Invest. Ophthalmol. Vis. Sci. 2016;57(12):2928.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Glaucoma filtration surgery usually fails because of post surgical scarring, a process in which fibroblasts play a prominent role. To elucidate the effects of rho-associated protein kinase (ROCK) inhibitor Y-27632 in post surgical scarring (fibrosis), we have now investigated the molecular mechanism with human tenon fibroblasts.

Methods : Human tenon fibroblasts were cultured with Y-27632 or various antiglaucoma drugs for indicated periods. After cultivation, we have prepared total RNA and protein samples from tenon fibroblasts. Using multiple RT-PCR array, we examined the factors respond to Y-27632. And, we have studied the expression of factor(s) of relating scarring formation using RT-PCR, immunoblot and immunofluorescence analysis. Also, we have examined the three-dimensional collagen gels cultivation for gel contraction by various antiglaucoma drugs.

Results : Collagen gel contraction by tenon fibroblasts was blocked in the presence of Y-27632. In multiple RT-PCR array using fibrosis-related genes, the expression of MMP-3 was down-regulated in tenon fibroblasts by additional Y-27632. Furthermore, immunoblot and immunoflurorescence analysis revealed that the expression of fibrosis markers was down-regulated in the presence of Y-27632.

Conclusions : These results suggest that the ROCK inhibitor Y-27632 may block scarring formation with interaction MMP-3 after glaucoma surgery. And, it will be possible that ROCK inhibitors and MMP-3 may have potential to be developed for treatment of glaucoma and other ocular diseases.

This is an abstract that was submitted for the 2016 ARVO Annual Meeting, held in Seattle, Wash., May 1-5, 2016.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×